本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

8.40
+0.46005.79%
盘前8.25-0.1500-1.79%06:35 EST
成交量:71.30万
成交额:601.34万
市值:5.77亿
市盈率:-4.65
高:8.80
开:7.90
低:7.82
收:7.94
52周最高:11.54
52周最低:2.86
股本:6,863.43万
流通股本:3,964.53万
量比:0.74
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-1.8064
每股收益(LYR):-2.2041
净资产收益率:-59.22%
总资产收益率:-34.41%
市净率:1.87
市盈率(LYR):-3.81

数据加载中...

2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/04

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/06

重要事件披露

Form 8-K - Current report